Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities

The summary for the Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Medicare and Medicaid Services, which is the U.S. government agency offering this grant.

Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities: CMS is soliciting proposals from interested parties to implement and operate cooperative agreement demonstration projects under the Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities as required by Section 122 of the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000 (BIPA). This legislation requires the Secretary of the Department of Health and Human Services (DHHS) to evaluate best practices and design, implement and evaluate demonstration projects for targeted ethnic and racial minorities. These demonstration projects will focus on new and innovative intervention models that improve the quality of items and services provided to target individuals in order to facilitate reduced disparities in early detection and treatment of cancer; improve clinical outcomes, satisfaction, quality of life, and appropriate use of Medicare-covered services and referral patterns among those target individuals with cancer; eliminate disparities in the rate of preventive cancer screening measures, such as pap smears and prostate cancer screenings, among target individuals; and promote collaboration with community-based organizations to ensure cultural competency of health care professionals and linguistic access for persons with limited English proficiency. Each project will stress the use of evidence-based, culturally competent models that will target efforts to decrease risk factors and increase screening rates and access to treatment and survival for cancers of the breast, cervix, colon, or prostate. The Congress authorized the Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities project for a potentially indefinite period of time, and appropriated $25 million in funding for the initial phase of the program. The demonstration projects will have a 3- to 5- year operation period. CMS will consider an award of up to $50,000 per demonstration project to cover initial implementation costs. The entire award will not be made initially but will be distributed incrementally between the time of conditional award and the approval of the demonstration by the Office of Management and Budget. CMS expects the costs of conducting these demonstration projects to range from $400,000 to $1.5 million per project per year. These costs will be reimbursed through capitation payment to the demonstration site. No State or local matching funds are required. CMS encourages applicants to propose innovative intervention models with the appropriate payment requirements and operational processes required to successfully implement the models. Through the solicitation, CMS intends to award at least 9 demonstration projects. CMS anticipates that projects will be awarded in mid-2005, and that project startup activities would begin immediately after completion of the waiver cost process (in late 2005). Each of the following four legislatively-mandated target populations are required to be the subject of two separate demonstration projects: American Indians (including Alaskan Natives, Eskimos, and Aleuts), Asian Americans and Pacific Islanders, Blacks, and Hispanics. In addition, of the nine demonstration projects, at least one must take place in a rural area and one in an inner-city area. Finally, one of the demonstration projects must be implemented in the Pacific Islands. The facilitation activities to be funded within this solicitation will focus on three areas of cancer disparity reduction: screening, diagnosis, and treatment. The applicant will provide facilitation services for two populations: (1) Medicare beneficiaries belonging to a defined ethnic or racial minority group who do not have a current diagnosis of cancer prior to enrollment in the demonstration project; and (2) Medicare beneficiaries belonging to a defined ethnic or racial minority who have been diagnosed with cancer prior to enrollment in the demonstration project. For the first population, the applicant must propose strategies for improving outcomes for cancers of the breast, cervix, colon and/or rectum, and prostate through facilitation of: (1) cancer screening services; (2) follow-up of abnormal findings and diagnosis; and (3) improved access to and follow-up of treatment and adjuvant treatment services. For the second population, the applicant must propose facilitation strategies to improve access to and follow-up of treatment and adjuvant treatment services for confirmed diagnosis of at least one of the demonstration-specified cancers and/or lung cancer. Projects are expected to use the best available scientific evidence to identify promising models of cancer detection and treatment to promote health and the appropriate utilization of Medicare covered services, in order to eliminate disparities in cancer detection and treatment among ethnic and racial populations of Medicare beneficiaries. Please note that certain requirements of the "CMS Grant Application Information Kit" do not exactly match the corresponding application requirements contained in Sections IV and V of the "Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities Funding Opportunity Announcement." For example, the "CMS Grant Application Information Kit" states that the summary abstract should not exceed 5 pages, whereas the CPTD FOA requires applicants to restrict their Executive Summary to 3 pages. While the "CMS Grant Application Information Kit" states that the project narrative portion of the application should not exceed 80 pages for a demonstration proposal, the CPTD FOA requires applicants to restrict their project narrative portion to 40 pages. The application requirements in the "Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities Funding Opportunity Announcement" will take precedence. Please address any questions about this matter to [email protected].